FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Pater

Research Profile

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Canada

Disorders

Procedures

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Joseph L Pater; J Rochon; M Parmar; P Selby
Future research and methodological approaches.
K Ding; Joseph L Pater; M Whitehead; Lesley Seymour; Frances A Shepherd
Validation of treatment induced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21.
James N Ingle; Dongsheng Tu; Joseph L Pater; Hyman Muss; Silvana Martino; Nicholas J Robert; Martine J Piccart; M Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Pater (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Joseph L Pater; J Rochon; M Parmar; P Selby
Future research and methodological approaches.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22 Suppl 7():vii57-vii61.
2008: K Ding; Joseph L Pater; M Whitehead; Lesley Seymour; Frances A Shepherd
Validation of treatment induced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21.
Contemporary clinical trials 2008;29(4):527-36.
2008: James N Ingle; Dongsheng Tu; Joseph L Pater; Hyman Muss; Silvana Martino; Nicholas J Robert; Martine J Piccart; M Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):877-82.
2008: Paul E Goss; James N Ingle; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Dongsheng Tu
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1948-55.
2008: Joseph L Pater; Dongsheng Tu; Lois Shepherd; James N Ingle; Paul E Goss
Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example.
Breast cancer research and treatment 2008;108(2):265-9.
2007: Michael D Brundage; David Osoba; Andrea Bezjak; Dongsheng Tu; Michael Palmer; Joseph L Pater
Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5078-81.
2007: David Osoba; Andrea Bezjak; Michael D Brundage; Joseph L Pater
Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10 Suppl 2():S138-45.
2007: H Richardson; D Johnston; Joseph L Pater; P Goss
The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial.
Current oncology (Toronto, Ont.) 2007;14(3):89-96.
2007: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2006-11.
2007: Christopher M Booth; Joseph L Pater; Paul E Goss
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.
Cancer 2007;109(9):1927-8; author reply 1928.
2007: Deborah J Dudgeon; Eduardo Bruera; Bruno Gagnon; Sharon M Watanabe; Sharon J Allan; David G Warr; Susan M MacDonald; Colleen Savage; Dongsheng Tu; Joseph L Pater
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Journal of pain and symptom management 2007;33(4):365-71.
2006: Jianhua Liu; Dongsheng Tu; Janet Dancey; Leonard Reyno; Kathleen I Pritchard; Joseph L Pater; Lesley K Seymour
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
Breast cancer research and treatment 2006;100(3):263-71.
2006: Beverly Moy; Dongsheng Tu; Joseph L Pater; James N Ingle; Lois E Shepherd; Timothy J Whelan; Paul E Goss
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1637-43.
2006: James N Ingle; Dongsheng Tu; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
Breast cancer research and treatment 2006;99(3):295-300.
2006: Rebecca K S Wong; Nancy Paul; Keyue Ding; Marlo Whitehead; Michael D Brundage; Anthony Fyles; Derek Wilke; Abdenour Nabid; André Fortin; Don Wilson; Michael McKenzie; Ida Ackerman; Luis Souhami; Pierre Chabot; Joseph L Pater
5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3458-64.
2005: Michael D Brundage; Deb Feldman-Stewart; A Leis; Andrea Bezjak; L Degner; K Velji; L Zetes-Zanatta; Dongsheng Tu; Paul Ritvo; Joseph L Pater
Communicating quality of life information to cancer patients: a study of six presentation formats.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6949-56.
2005: Timothy J Whelan; Paul E Goss; James N Ingle; Joseph L Pater; Dongsheng Tu; Kathleen Pritchard; Shifang Liu; Lois E Shepherd; Michael Palmer; Nicholas J Robert; Silvana Martino; Hyman Muss
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6931-40.
2005: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Journal of the National Cancer Institute 2005;97(17):1262-71.
2005: David Barbic; Joseph L Pater; Robert J Brison
Comparison of mouth guard designs and concussion prevention in contact sports: a multicenter randomized controlled trial.
Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 2005;15(5):294-8.
2005: Yandong Ouyang; Dongguang Li; Joseph L Pater; Mark Levine
The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer.
Breast cancer research and treatment 2005;92(2):115-23.
2005: Graeme G Duncan; Joel B Epstein; Dongsheng Tu; Samy El-Sayed; Andrea Bezjak; Jon Ottaway; Joseph L Pater
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Head & neck 2005;27(5):421-8.
2005: Joseph L Pater; Paul Goss; Jame Ingle; Wendy Shelley; Lois Shepherd
The ethics of early stopping rules.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2862-3; author reply 2863-4.
2005: Aileen M Davis; Brian O'Sullivan; Robert E Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Alex Hammond; Veronique Benk; Rita Kandel; Karen Goddard; Carolyn Freeman; Anna Sadura; Benny Zee; Andrew Day; Dongsheng Tu; Joseph L Pater
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(1):48-53.
2005: David Osoba; Andrea Bezjak; Michael D Brundage; Benny Zee; Dongsheng Tu; Joseph L Pater
Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.
European journal of cancer (Oxford, England : 1990) 2005;41(2):280-7.
2003: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
The New England journal of medicine 2003;349(19):1793-802.
2003: Theodora Voskoglou-Nomikos; Joseph L Pater; Lesley Seymour
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4227-39.
2003: Michael D Brundage; A Leis; Andrea Bezjak; Deb Feldman-Stewart; L Degner; K Velji; L Zetes-Zanatta; Dongsheng Tu; Paul Ritvo; Joseph L Pater
Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):395-404.
2003: Karen W L Yee; Joseph L Pater; Lam Pho; Benny Zee; Lillian L Siu
Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1618-23.
2002: Aileen M Davis; Brian O'Sullivan; Robert S Bell; Robert E Turcotte; Charles Catton; Jay S Wunder; Pierre Chabot; A Hammond; Veronique Benk; M Isler; Carolyn Freeman; Karen Goddard; Andrea Bezjak; Rita A Kandel; Anna Sadura; A Day; K James; Dongsheng Tu; Joseph L Pater; Benny Zee
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4472-7.
2002: Andrea Bezjak; Peter Dixon; Michael D Brundage; Dongsheng Tu; Michael J Palmer; Paul Blood; Clive Grafton; Catherine Lochrin; Carson Leong; Liam Mulroy; Colum Smith; James Wright; Joseph L Pater
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15).
International journal of radiation oncology, biology, physics 2002;54(3):719-28.
2002: Samy El-Sayed; Abdenour Nabid; W Shelley; J Hay; J Balogh; M Gelinas; R MacKenzie; N Read; E Berthelet; H Lau; Joel B Epstein; P Delvecchio; P K Ganguly; F Wong; P Burns; Dongsheng Tu; Joseph L Pater
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3956-63.
2002: Brian O'Sullivan; Aileen M Davis; Robert E Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph L Pater; Benny Zee
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.
Lancet 2002;359(9325):2235-41.
2002: William K Evans; Marilyn Nefsky; Joseph L Pater; George Browman; Donald H Cowan
Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
Chronic diseases in Canada 2002;23(4):152-6.
2001: Joseph L Pater; George Browman; Melissa Brouwers; M F Nefsky; William K Evans; Donald H Cowan
Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3392-6.
2000: Peter Kirkbride; Andrea Bezjak; Joseph L Pater; Benny Zee; Michael J Palmer; Rebecca Wong; P Cross; S Gulavita; P Blood; A Sun; G Dundas; P K Ganguly; J Lim; A D Chowdhury; S E Kumar; A R Dar
Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1960-6.
1999: H Quon; Frances A Shepherd; D G Payne; P Coy; N Murray; R Feld; Joseph L Pater; Anna Sadura; Benny Zee
The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.
International journal of radiation oncology, biology, physics 1999;43(1):39-45.
1998: Paul J Hoskins; Dongsheng Tu; K James; Joseph L Pater; B Koski
Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups.
Gynecologic oncology 1998;70(2):224-30.
1998: Benny Zee; B Cole; T Li; George Browman; K James; D Johnston; D Sugano; Joseph L Pater
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2834-9.
1998: Joseph L Pater; David Osoba; Benny Zee; WS Lofters; M Gore; E Dempsey; Michael Palmer; C Chin
Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1998;7(3):273-8.
1998: Jean Latreille; Joseph L Pater; D Johnston; Francis Laberge; D Stewart; JJ Rusthoven; Paul J Hoskins; Brian Findlay; E McMurtrie; Louise Yelle; C Williams; D Walde; S Ernst; H Dhaliwal; David Warr; Frances A Shepherd; D Mee; L Nishimura; David Osoba; Benny Zee
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1174-8.
1998: Michael Crump; Stefan Gluck; Kathleen Pritchard; Lois Shepherd; Joseph L Pater
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):800-2.
1998: David Osoba; George Rodrigues; J Myles; Benny Zee; Joseph L Pater
Interpreting the significance of changes in health-related quality-of-life scores.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):139-44.
1997: Joseph L Pater; Benny Zee; Michael Palmer; D Johnston; David Osoba
Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(5):410-3.
1997: I Quirt; S Micucci; L A Moran; Joseph L Pater; George Browman
Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1997;1(3):241-8.
1997: WS Lofters; Joseph L Pater; Benny Zee; E Dempsey; D Walde; J P Moquin; K Wilson; Paul J Hoskins; R M Guevin; S Verma; R Navari; J E Krook; J Hainsworth; Michael Palmer; C Chin
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2966-73.
1997: David Osoba; Benny Zee; David Warr; Jean Latreille; L Kaizer; Joseph L Pater
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(4):307-13.
1997: Joseph Michael Connors; Paul Klimo; G Adams; B F Burns; I Cooper; Ralph M Meyer; Susan E O'Reilly; Joseph L Pater; I Quirt; Anna Sadura; Chaim Shustik; JR Skillings; S Sutcliffe; S Verma; S Yoshida; Benny Zee
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1638-45.
1997: J Dancey; Benny Zee; David Osoba; M Whitehead; F Lu; L Kaizer; Jean Latreille; Joseph L Pater
Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(2):151-8.
1997: Joseph L Pater; WS Lofters; Benny Zee; E Dempsey; D Walde; J P Moquin; K Wilson; Paul J Hoskins; R M Guevin; S Verma; R Navari; J E Krook; J Hainsworth; Michael Palmer; C Chin
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):181-5.
1997: David Osoba; Benny Zee; Joseph L Pater; David Warr; Jean Latreille; L Kaizer
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):116-23.
1996: Chris Coppin; M K Gospodarowicz; K James; I F Tannock; Benny Zee; J Carson; Joseph L Pater; LD Sullivan
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2901-7.
1996: Deb Feldman-Stewart; S Chammas; Charles Hayter; Joseph L Pater; William J Mackillop
An empirical approach to informed consent in ovarian cancer.
Journal of clinical epidemiology 1996;49(11):1259-69.
1996: Kathleen I Pritchard; A H Paterson; N A Paul; Benny Zee; S Fine; Joseph L Pater
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2731-7.
1996: Eric J Bow; L A Mandell; T J Louie; R Feld; M Palmer; B Zee; Joseph L Pater
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Annals of internal medicine 1996;125(3):183-90.
1996: David Osoba; Benny Zee; David Warr; L Kaizer; Jean Latreille; Joseph L Pater
Quality of life studies in chemotherapy-induced emesis.
Oncology 1996;53 Suppl 1():92-5.
1996: L L Siu; F A Shepherd; N Murray; R Feld; Joseph L Pater; Benny Zee
Influence of age on the treatment of limited-stage small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):821-8.
1996: David Osoba; J Dancey; Benny Zee; J Myles; Joseph L Pater
Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
Journal of the National Cancer Institute. Monographs 1996;(20):107-11.
1995: Joseph L Pater; Benny Zee; J Myles; J P Pignon; C Milan; TM Sahmoud; Valter Torri; Silvia Marsoni
A proposal for a new approach to intergroup cancer trials.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):1921-3.
1995: B Raby; Joseph L Pater; William J Mackillop
Does knowledge guide practice? Another look at the management of non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1904-11.
1994: Nevin Murray; Chris Coppin; Andrew J Coldman; Joseph L Pater; E Rapp
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2333-9.
1994: David Osoba; Benny Zee; Joseph L Pater; David Warr; L Kaizer; Jean Latreille
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1994;3(5):353-64.
1994: L Kaizer; David Warr; Paul J Hoskins; Jean Latreille; WS Lofters; J Yau; Michael Palmer; Benny Zee; M Levy; Joseph L Pater
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1050-7.
1994: Joseph L Pater; L Slamet; Benny Zee; David Osoba; David Warr; JJ Rusthoven
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(3):161-6.
1993: H E Niezgoda; Joseph L Pater
A validation study of the domains of the core EORTC quality of life questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1993;2(5):319-25.
1993: Michael D Brundage; Joseph L Pater; Benny Zee
Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.
Journal of the National Cancer Institute 1993;85(14):1138-48.
1993: Ronald Feld; Joseph L Pater; Pamela J Goodwin; R Grossman; P Coy; Nevin Murray
The restaging of responding patients with limited small cell lung cancer. Is it really useful?
Chest 1993;103(4):1010-6.
1993: Nevin Murray; P Coy; Joseph L Pater; I Hodson; A Arnold; Benny Zee; D Payne; E C Kostashuk; W K Evans; P Dixon
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):336-44.
1992: Eric J Bow; A Chow; C R Elliott; R Feld; T J Louie; L Mandell; L Miedzinski; Joseph L Pater; N Paul; H G Robson; A Belch; A R Willan
Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 1992;3(5):235-9.
1992: Anna Sadura; Joseph L Pater; David Osoba; M Levine; M Palmer; K Bennett
Quality-of-life assessment: patient compliance with questionnaire completion.
Journal of the National Cancer Institute 1992;84(13):1023-6.
1992: David Warr; A Wilan; P Venner; Joseph L Pater; L Kaizer; Francis Laberge; Jean Latreille; D Stewart; G O'Connell; David Osoba
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):33-6.
1991: JJ Rusthoven; Joseph L Pater; L Kaizer; K Wilson; David Osoba; Jean Latreille; Brian Findlay; WS Lofters; David Warr; Francis Laberge
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):681-6.
1991: A R Belch; D E Bergsagel; K Wilson; S O'Reilly; J Wilson; D Sutton; Joseph L Pater; D Johnston; Benny Zee
Effect of daily etidronate on the osteolysis of multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1397-402.
1991: J Skillings; C Cripps; Elizabeth Eisenhauer; Joseph L Pater; S Verma; D Walde
A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.
Investigational new drugs 1991;9(1):79-82.
1990: L Jaakkimainen; Pamela J Goodwin; Joseph L Pater; P Warde; Nevin Murray; E Rapp
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1301-9.
1990: Elizabeth A Eisenhauer; K I Pritchard; D J Perrault; S Verma; Joseph L Pater
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
Investigational new drugs 1990;8(3):283-7.
1988: Elizabeth A Eisenhauer; Benny Zee; Joseph L Pater; W R Walsh
Trimetrexate: predictors of severe or life-threatening toxic effects.
Journal of the National Cancer Institute 1988;80(16):1318-22.
1988: Pamela J Goodwin; R Feld; W K Evans; Joseph L Pater
Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1537-47.
1988: E Rapp; Joseph L Pater; A Willan; Y Cormier; Nevin Murray; W K Evans; D I Hodson; D A Clark; Ronald Feld; A M Arnold
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):633-41.
1987: Ronald Feld; W K Evans; P Coy; I Hodson; A S MacDonald; David Osoba; D Payne; W Shelley; Joseph L Pater
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1401-9.
1986: Jean Maroun; A Maksymiuk; Elizabeth Eisenhauer; David J Stewart; V Young; Joseph L Pater
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Cancer treatment reports 1986;70(11):1327-8.
1986: W K Evans; Ronald Feld; N Murray; Joseph L Pater; W Shelley; A Willan; David Osoba; M Levitt; P Coy; I Hodson
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.
Seminars in oncology 1986;13(3 Suppl 3):10-6.
1985: R Feld; T J Louie; L Mandell; Eric J Bow; H G Robson; A Chow; A Belch; L Miedzinski; Anita Rachlis; Joseph L Pater
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Archives of internal medicine 1985;145(6):1083-8.
1984: W Shelley; P Kersey; I Quirt; Joseph L Pater
Survey of surgical management of malignant melanoma in Canada: optimal margins of excision and lymph-node dissection.
Canadian journal of surgery. Journal canadien de chirurgie 1984;27(2):190-2.